Post by PRGX Global Inc.

𝟓 𝐑𝐞𝐚𝐬𝐨𝐧𝐬 𝐭𝐡𝐞 𝐓𝐢𝐦𝐞 𝐭𝐨 𝐀𝐜𝐭 𝐨𝐧 𝐂𝐥𝐢𝐧𝐢𝐜𝐚𝐥 𝐓𝐫𝐢𝐚𝐥 𝐂𝐨𝐧𝐭𝐫𝐚𝐜𝐭 𝐂𝐨𝐦𝐩𝐥𝐢𝐚𝐧𝐜𝐞 𝐢𝐬 𝐍𝐨𝐰 There's never been a bigger opportunity – or a bigger risk – when it comes to clinical trial spend. Here are 5 reasons the timing is right: 1️⃣ Clinical trial investment is surging: GLP-1, oncology, gene therapies, which means more trials, more sites, more CROs, more complexity 2️⃣ Strong revenue doesn't mean margin pressure disappears: patent cliffs, biosimilar competition, and pricing pressures are squeezing margins 3️⃣ Pharma is ready for AI: purpose-built AI can now analyze contract performance at a scale that wasn't possible before 4️⃣ Complexity is compounding: global trials, decentralized models, and multi-year timelines mean manual processes can't keep up 5️⃣ The backlog is real: post-COVID restarts and new trial launches have created years of unaudited spend sitting in closed and active trials The opportunity to recover and prevent overpayments is bigger than ever. The sooner you begin, the faster recoveries hit your bottom line. 👉 See how PRGX helps pharma and biotech companies take action on clinical trial spend: https://lnkd.in/gUEa9cU8 #ClinicalTrials #Pharma #Biotech #ContractCompliance #SpendManagement #ClinicalResearch #PRGX